Axa
OGN icon

Axa’s Organon & Co OGN Stock Holding History

Axa’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-216,869
Closed -$2.1M – 737
2025
Q2 		$2.1M Sell
216,869
-25,440
-10% -$262K 0.01% 768
2025
Q1 		$3.61M Sell
242,309
-7,292
-3% -$112K 0.01% 618
2024
Q4 		$3.72M Buy
249,601
+8,936
+4% +$146K 0.01% 618
2024
Q3 		$4.6M Sell
240,665
-69,835
-22% -$1.45M 0.01% 569
2024
Q2 		$6.43M Sell
310,500
-49,366
-14% -$981K 0.02% 479
2024
Q1 		$6.77M Buy
359,866
+46,166
+15% +$792K 0.02% 487
2023
Q4 		$4.52M Sell
313,700
-426,500
-58% -$5.8M 0.01% 573
2023
Q3 		$12.8M Buy
740,200
+76,302
+11% +$1.59M 0.05% 347
2023
Q2 		$13.8M Buy
663,898
+185,720
+39% +$4.04M 0.05% 352
2023
Q1 		$11.2M Buy
478,178
+1,978
+0.4% +$53.1K 0.04% 393
2022
Q4 		$13.3M Buy
+476,200
New +$12.2M 0.05% 382

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

Axa's OGN Position: Q3 2025 in Review

Axa sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 216,869 shares — an estimated $2.1M sold.

Axa first reported a position in OGN in Q4 2022 and held it in 11 quarters. The position peaked at $13.8M in Q2 2023. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Axa reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Axa sold 216,869 Organon & Co shares in Q3 2025, an estimated $2.1M.
  • Axa first reported a position in Organon & Co in Q4 2022 and held it in 11 quarters.
  • Axa's Organon & Co position peaked at $13.8M in Q2 2023.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.